1. How is cancer virotherapy different from cancer chemotherapy?
2. What is an adenovirus made of and what does it look like?
3. What typically happens after an adenovirus attaches to the surface of a target cell?
4. What risks are inherent in cancer virotherapy?
5. What is the goal of transductional targeting, and how does it work?
6. What is the goal of transcriptional targeting, and how does it work?
7. How do the proteins called p53 and Rb help make cancer virotherapy safer?